Lockheed Martin Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Lockheed Martin Investment Management's LLY Position: Q1 2026 in Review
Lockheed Martin Investment Management increased its Eli Lilly (LLY) stake by 21% in Q1 2026, buying an estimated $2.54M and bringing the position to 14,590 shares worth $13.4M. The position accounts for 0.49% of the portfolio, ranked #43.
Lockheed Martin Investment Management first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $30.5M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Lockheed Martin Investment Management held 14,590 shares of Eli Lilly worth $13.4M as of Q1 2026.
- Lockheed Martin Investment Management bought 2,510 Eli Lilly shares in Q1 2026, an estimated $2.54M.
- Eli Lilly made up 0.49% of Lockheed Martin Investment Management's portfolio in Q1 2026, its #43 holding.
- Lockheed Martin Investment Management first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
- Lockheed Martin Investment Management's Eli Lilly position peaked at $30.5M in Q2 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Lockheed Martin Investment Management's 13F filing for Q1 2026, filed 7 May 2026.